大麻药品市场：按品牌、产品类型、分销管道、用途- 全球预测 2023-2030

预计2023年全球大麻药品市场将大幅成长，达到14.4934亿美元，复合年增长率为18.73%，2030年将达到48.2656亿美元。

FPNV定位矩阵

FPNV 定位矩阵对于评估全球大麻药品市场至关重要。透过检查业务策略和产品满意度的关键指标，我们对供应商进行全面评估，使您能够根据您的特定需求做出明智的资讯。这种进阶分析将供应商分为四个像限，并取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市占率分析

市场占有率分析可以深入了解供应商在特定市场领域的当前地位。比较供应商对总收入、基本客群和其他关键指标的贡献，可以帮助公司更好地了解他们在争夺市场份额时的表现以及面临的情况。该分析还揭示了特定行业的竞争程度、累积和合併的优势以及研究基准年的合併特征。

本报告提供了以下几点见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开发：提供有关利润丰厚的新兴市场的详细资讯，并分析其在成熟市场的渗透率。

3. 市场多元化：提供有关新产品发布、未开发领域、最新发展和投资的详细资讯。

4.市场趋势：全面了解COVID-19、俄罗斯-乌克兰衝突和高通膨的累积影响。

5.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

6. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告回答了以下问题：

1. 大麻药品的全球市场规模与预测为何？

2.在预测期内，COVID-19对全球大麻药品市场的阻碍因素与影响有哪些？

3. 在预测期内，全球大麻药品市场需要投资哪些产品/细分市场/应用/领域？

4. 全球大麻医学市场的竞争策略是什么？

5. 全球大麻医学市场的技术趋势和法律规范是什么？

6. 全球大麻药品市场主要供应商的市占率是多少？

7. 哪些型态和策略性倡议被认为适合进入全球大麻药品市场？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

• 市场动态
  • 促进因素
    • 世界各地医用大麻合法化程度不断提高
    • 人们越来越认识到大麻二酚的医学益处及其治疗作用
    • 越来越多地使用大麻为基础的药物来治疗发炎、慢性疼痛和睡眠障碍等各种适应症
  • 抑制因素
    • 与医用大麻相关的高价格
  • 机会
    • 製药公司加大对 CBD 开发和大麻素法规的投资
    • 创新和新产品发布
  • 任务
    • 市面上有多种替代品
• 市场趋势
• COVID-19 的累积影响
• 俄罗斯-乌克兰衝突的累积影响
• 高通膨的累积效应
• 波特五力分析
• 价值炼和关键路径分析
• 法律规范
• 客户客製化

第6章以品牌分類的大麻药品市场

• Epidiolex
• 萨蒂克斯

第7章大麻药品市场：依产品类型

• 软膏和霜
• 固体和可溶性粉末和油

第8章大麻药品市场：按分销管道

• 医院药房
• 网路药房
• 零售药房

第9章大麻药品市场：依用途

• 关节炎
• 癌症
• 癫痫
• 偏头痛

第10章美洲大麻医学市场

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美国

第11章亚太大麻药品市场

• 澳洲
• 中国
• 印度
• 印尼
• 日本
• 马来西亚
• 菲律宾
• 新加坡
• 韩国
• 台湾
• 泰国
• 越南

第12章欧洲、中东和非洲大麻医学市场

• 丹麦
• 埃及
• 芬兰
• 法国
• 德国
• 以色列
• 义大利
• 荷兰
• 奈及利亚
• 挪威
• 波兰
• 卡达
• 俄罗斯
• 沙乌地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公国
• 英国

第13章竞争形势

• FPNV定位矩阵
• 市占率分析：主要企业
• 竞争情境分析：主要企业

第14章上市公司名单

第15章附录

• 讨论指南
• 关于许可证和定价

The Global Cannabis Pharmaceuticals Market is forecasted to grow significantly, with a projected USD 1,449.34 million in 2023 at a CAGR of 18.73% and expected to reach a staggering USD 4,826.56 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Cannabis Pharmaceuticals Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Cannabis Pharmaceuticals Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Brand, market is studied across Epidiolex and Sativex. The Epidiolex is projected to witness significant market share during forecast period.

Based on Product Type, market is studied across Ointments & Creams and Solids and Dissolvable Powder & Oil. The Solids and Dissolvable Powder & Oil is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Retail Pharmacies is projected to witness significant market share during forecast period.

Based on Application, market is studied across Arthritis, Cancer, Epilepsy, and Migraine. The Arthritis is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Cannabis Pharmaceuticals Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Cannabis Pharmaceuticals Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cannabis Pharmaceuticals Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cannabis Pharmaceuticals Market?

4. What is the competitive strategic window for opportunities in the Global Cannabis Pharmaceuticals Market?

5. What are the technology trends and regulatory frameworks in the Global Cannabis Pharmaceuticals Market?

6. What is the market share of the leading vendors in the Global Cannabis Pharmaceuticals Market?

7. What modes and strategic moves are considered suitable for entering the Global Cannabis Pharmaceuticals Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Cannabis Pharmaceuticals Market, by Brand, 2022 vs 2030
• 4.3. Cannabis Pharmaceuticals Market, by Product Type, 2022 vs 2030
• 4.4. Cannabis Pharmaceuticals Market, by Distribution Channel, 2022 vs 2030
• 4.5. Cannabis Pharmaceuticals Market, by Application, 2022 vs 2030
• 4.6. Cannabis Pharmaceuticals Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the legalization of medicinal cannabis worldwide
    • 5.1.1.2. Growing awareness about the medical benefits of cannabidiol and its remedial properties
    • 5.1.1.3. Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, and sleep disorders
  • 5.1.2. Restraints
    • 5.1.2.1. High price associated with the medical cannabis
  • 5.1.3. Opportunities
    • 5.1.3.1. Rise in investments by pharma companies in CBD and developments for cannabinoid regulation
    • 5.1.3.2. Innovation and launching new products
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of various alternatives in the market
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Cannabis Pharmaceuticals Market, by Brand

• 6.1. Introduction
• 6.2. Epidiolex
• 6.3. Sativex

7. Cannabis Pharmaceuticals Market, by Product Type

• 7.1. Introduction
• 7.2. Ointments & Creams
• 7.3. Solids and Dissolvable Powder & Oil

8. Cannabis Pharmaceuticals Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Hospital Pharmacies
• 8.3. Online Pharmacies
• 8.4. Retail Pharmacies

9. Cannabis Pharmaceuticals Market, by Application

• 9.1. Introduction
• 9.2. Arthritis
• 9.3. Cancer
• 9.4. Epilepsy
• 9.5. Migraine

10. Americas Cannabis Pharmaceuticals Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Cannabis Pharmaceuticals Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Cannabis Pharmaceuticals Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. CANNABIS PHARMACEUTICALS MARKET RESEARCH PROCESS
• FIGURE 2. CANNABIS PHARMACEUTICALS MARKET SIZE, 2022 VS 2030
• FIGURE 3. CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2022 VS 2030 (%)
• FIGURE 5. CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2030 (%)
• FIGURE 6. CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
• FIGURE 7. CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 8. CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. CANNABIS PHARMACEUTICALS MARKET DYNAMICS
• FIGURE 10. CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. CANNABIS PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 5. CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 11. CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 33. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 55. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 59. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 128. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 129. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 130. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 144. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 146. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 148. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 149. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 188. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 189. CANNABIS PHARMACEUTICALS MARKET LICENSE & PRICING